MA44386A - Systèmes et méthodes de prédiction de demi-vie vitréenne de conjugués d'agent thérapeutique et de polymère - Google Patents
Systèmes et méthodes de prédiction de demi-vie vitréenne de conjugués d'agent thérapeutique et de polymèreInfo
- Publication number
- MA44386A MA44386A MA044386A MA44386A MA44386A MA 44386 A MA44386 A MA 44386A MA 044386 A MA044386 A MA 044386A MA 44386 A MA44386 A MA 44386A MA 44386 A MA44386 A MA 44386A
- Authority
- MA
- Morocco
- Prior art keywords
- vitrean
- life
- systems
- methods
- therapeutic agent
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/10—Complex mathematical operations
- G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Data Mining & Analysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Pure & Applied Mathematics (AREA)
- Computational Mathematics (AREA)
- Mathematical Analysis (AREA)
- Mathematical Optimization (AREA)
- Mathematical Physics (AREA)
- Computing Systems (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Databases & Information Systems (AREA)
- Probability & Statistics with Applications (AREA)
- Algebra (AREA)
- Operations Research (AREA)
- Evolutionary Biology (AREA)
- Software Systems (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562238393P | 2015-10-07 | 2015-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA44386A true MA44386A (fr) | 2019-01-23 |
Family
ID=57211573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA044386A MA44386A (fr) | 2015-10-07 | 2016-10-05 | Systèmes et méthodes de prédiction de demi-vie vitréenne de conjugués d'agent thérapeutique et de polymère |
Country Status (7)
Country | Link |
---|---|
US (1) | US20180293360A1 (fr) |
EP (1) | EP3360066A1 (fr) |
JP (1) | JP2019501864A (fr) |
CN (1) | CN108369611A (fr) |
HK (1) | HK1259021A1 (fr) |
MA (1) | MA44386A (fr) |
WO (1) | WO2017062407A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011517451A (ja) | 2008-03-28 | 2011-06-09 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ポリペプチド−ポリマー抱合体およびその使用方法 |
WO2017100470A1 (fr) | 2015-12-09 | 2017-06-15 | The Regents Of The University Of California | Méthodes de traitement d'une maladie ou d'un trouble oculaire |
IL311121A (en) | 2017-03-27 | 2024-04-01 | Regeneron Pharma | Sterilization method |
CN107261124B (zh) * | 2017-06-09 | 2020-05-22 | 山东大学 | 一种新生血管生成抑制肽及其透明质酸修饰物的制备方法与应用 |
US20210244822A1 (en) * | 2018-06-25 | 2021-08-12 | The Board Of Regents Of The University Of Oklahoma | Conjugates with internal and terminal-end heparosan linkages |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2104518T1 (es) | 1994-03-07 | 1997-10-16 | Dow Chemical Co | Conjugados dendrimeros bioactivos y/o directores hacia diana. |
US5675063A (en) | 1995-02-28 | 1997-10-07 | Loyola University Of Chicago | Immortalized rabbit hybridoma fusion partner |
KR19990085365A (ko) | 1998-05-16 | 1999-12-06 | 허영섭 | 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법 |
BRPI0613401B8 (pt) * | 2005-10-18 | 2021-05-25 | Allergan Inc | composição oftálmica compreendendo derivados de glicocorticoides que penetram seletivamente nos tecidos do segmento posterior |
US20110064717A1 (en) | 2009-08-20 | 2011-03-17 | Ramot At Tel-Aviv University Ltd. | Homing endonuclease genes and their targets |
WO2011066417A2 (fr) | 2009-11-24 | 2011-06-03 | Carnegie Mellon University | Anticorps et conjugués pour des modulateurs d'angiogenèse |
CN106957356B (zh) * | 2010-05-11 | 2021-05-25 | 弗雷德哈钦森癌症研究中心 | 氯毒素变体、缀合物及其使用方法 |
EP2935589A1 (fr) | 2012-12-18 | 2015-10-28 | Novartis AG | Compositions et procédés qui utilisent une étiquette peptidique qui se lie au hyaluronane |
-
2016
- 2016-10-05 MA MA044386A patent/MA44386A/fr unknown
- 2016-10-05 EP EP16788599.5A patent/EP3360066A1/fr not_active Withdrawn
- 2016-10-05 US US15/766,319 patent/US20180293360A1/en not_active Abandoned
- 2016-10-05 JP JP2018517541A patent/JP2019501864A/ja not_active Ceased
- 2016-10-05 WO PCT/US2016/055421 patent/WO2017062407A1/fr active Application Filing
- 2016-10-05 CN CN201680071297.8A patent/CN108369611A/zh active Pending
-
2019
- 2019-01-29 HK HK19101509.1A patent/HK1259021A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN108369611A (zh) | 2018-08-03 |
JP2019501864A (ja) | 2019-01-24 |
WO2017062407A1 (fr) | 2017-04-13 |
US20180293360A1 (en) | 2018-10-11 |
HK1259021A1 (zh) | 2019-11-22 |
EP3360066A1 (fr) | 2018-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
IL258533B (en) | Acoustic orthopedic monitoring system and methods | |
BR112017002511A2 (pt) | sistemas e métodos de almofada terapêutica | |
MA49715A (fr) | Oligomères et conjugués d'oligomères | |
DK3180907T3 (da) | Lægemiddelinformationssystem og fremgangsmåde | |
IL262387A (en) | Arginase inhibitors and their treatment applications | |
BR112016018549A2 (pt) | sistemas e métodos para cura de tecido | |
DK3035926T3 (da) | Forbindelser og fremgangsmåder til behandling af en epilepsilidelse | |
DK3107563T3 (da) | Glycomålrettede terapeutiske midler | |
MA44386A (fr) | Systèmes et méthodes de prédiction de demi-vie vitréenne de conjugués d'agent thérapeutique et de polymère | |
MA44262A (fr) | Bioconjugués et utilisations de ceux-ci | |
FR3041114B1 (fr) | Articulation de lunettes et lunettes correspondantes | |
DK2968470T3 (da) | Modificeret müllersk inhiberende substans (mis)-proteiner og anvendelser deraf til behandlingen af sygdomme | |
DK3060226T3 (da) | Fagterapi af pseudomonasinfektioner | |
DK3316951T3 (da) | Eyewear and flexible elements | |
KR102213006B9 (ko) | 멀티 광 섬유 감지 시스템 | |
FR3025964B3 (fr) | Audit d'applications mobiles | |
FR3036598B1 (fr) | Dispositif d'application et de massage | |
MA40524A (fr) | Dérivés d'adrénomédulline stabilisés et leur utilisation | |
FI20136079A (fi) | Menetelmä ja järjestelmä geeniperimän terveyden arvioimiseksi | |
DK3132279T3 (da) | Målbestemmelsesfremgangsmåde og -system | |
DK3488521T3 (da) | Køleapparat-kompressorsystem og anvendelse | |
MA42130A (fr) | Combinaisons d'opioïdes et de n-acyléthanolamines | |
DK3096255T3 (da) | System til håndtering af anvendelsen af medicinske indretninger | |
MA45326A (fr) | Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation |